← Leaderboards
Nathan Michel Johnson
Tulane University Of Louisiana
$201,096
Attributed
$201,096
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2018–21$100K$75K$50K$25K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$201,096 · 2
By mechanism
F30$201,096 · 2
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Rudolf P Bohm$51,450,972
- Ronald S. Veazey$44,796,137
- Mario Tomas Philipp$11,469,177
- James L Blanchard$16,717,439
- Juan J. L. Lertora$4,837,795
Others in their field
Other Emerging Leaders on “Acquired Immunodeficiency Syndrome”
- Kimberly Smith · Ppd Development Lp$122,008,792
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,132,816
- Bambra Strokes · Ppd Development Lp$65,000,267
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
Research focus
Acquired Immunodeficiency SyndromeAffectAdoptive TransferAnimal ModelAnimalsAntigen BindingAntigensAids/Hiv ProblemBaseBindingCd4 Positive T LymphocytesCell LineCellsCellular TransductionCessation Of LifeChimeric Antigen ReceptorAntiretroviral TherapyChimeric ProteinsClinicClinical EfficacyClinical TrialsCohortCostCytomegalovirus
Grant awards (4)
Modifying CMV-specificT cells with a novel bicistronic CD4-CAR/maC46 vector to target HIV$51,036
F30 · FY2021 · AI · contact PI
Modifying CMV-specificT cells with a novel bicistronic CD4-CAR/maC46 vector to target HIV$50,520
F30 · FY2020 · AI · contact PI
Modifying CMV-specificT cells with a novel bicistronic CD4-CAR/maC46 vector to target HIV$50,016
F30 · FY2019 · AI · contact PI
Modifying CMV-specificT cells with a novel bicistronic CD4-CAR/maC46 vector to target HIV$49,524
F30 · FY2018 · GM · contact PI